0001104659-21-033323.txt : 20210308
0001104659-21-033323.hdr.sgml : 20210308
20210308164228
ACCESSION NUMBER: 0001104659-21-033323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210305
FILED AS OF DATE: 20210308
DATE AS OF CHANGE: 20210308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOORHEAD DANIEL J
CENTRAL INDEX KEY: 0001536000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38804
FILM NUMBER: 21722508
MAIL ADDRESS:
STREET 1: 9777 PYRAMID CT
STREET 2: STE 100
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZYNEX INC
CENTRAL INDEX KEY: 0000846475
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 870403828
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9555 MAROON CIRCLE
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
BUSINESS PHONE: (303) 867-3904
MAIL ADDRESS:
STREET 1: 9555 MAROON CIRCLE
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
FORMER COMPANY:
FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC
DATE OF NAME CHANGE: 20050812
FORMER COMPANY:
FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC
DATE OF NAME CHANGE: 20040120
FORMER COMPANY:
FORMER CONFORMED NAME: FOX RIVER HOLDINGS INC
DATE OF NAME CHANGE: 20031126
4
1
tm219055d1_form4.xml
FORM 4
X0306
4
2021-03-05
0
0000846475
ZYNEX INC
ZYXI
0001536000
MOORHEAD DANIEL J
C/O ZYNEX, INC.
9555 MAROON CIRCLE
ENGLEWOOD
CO
80112
0
1
0
0
Chief Financial Officer
Common Stock (Restricted Stock Award)
2021-03-05
4
A
0
5000
0
A
99949
D
Common Stock
2021-03-05
4
F
0
1359
14.75
D
31374
D
Represents a restricted stock award issued pursuant to the Issuer's 2017 Stock Incentive Plan (the "Plan") pursuant to which the 5,000 shares vest equally, on an annual basis, over a period of four years beginning one year from the grant date.
Represents restricted stock awards under the Plan, which have not vested.
Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of Restricted Stock Awards ("RSAs") and does not represent a sale.
/s/ Daniel Moorhead
2021-03-08